NCT02324296View on ClinicalTrials.gov

PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

January 31, 2009

Study Completion Date

December 31, 2010

Conditions
Small Cell Lung Cancer
Interventions
DRUG

ifosfamide

PEI regimen may be a possible therapeutic option, with high activity and an acceptable toxicity profile.

All Listed Sponsors
lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

NCT02324296 - PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases | Biotech Hunter | Biotech Hunter